The Effect of Ixazomib on the Latent HIV Reservoir
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine the safety and tolerability of Ixazomib in HIV
infected patients who are on a stable regimen of ART that suppresses HIV replication. A
secondary goal is to determine the effect of ixazomib on the size of the HIV reservoir.